New research reveals that sunburn’s acute effects, like inflammation and cell death, are triggered by RNA damage rather than DNA damage. This discovery reshapes our understanding of the skin’s defense against UV radiation and opens doors to innovative treatments for sun-related skin conditions.

For decades, we’ve believed the bright redness of sunburn — along with its irritating sting and peeling skin — was the result of ultraviolet (UV) radiation wreaking havoc on DNA. But now, a new study from researchers at the University of Copenhagen and Nanyang Technological University in Singapore suggests otherwise.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Researchers have discovered that DNA and RNA epigenetics form a complementary system that precisely regulates gene activity, with potential implications for understanding cancer.

This is where DNA and RNA epigenetics comes in: a series of mechanisms that act as "markers" on genes, to control their activity without modifying the DNA or RNA sequence itself. Until now, DNA and RNA epigenetics were studied as independent systems.

Sunburn has traditionally been attributed to UV-induced DNA damage. However, a new study reveals that RNA, another vital cellular molecule, plays a major role in triggering acute sunburn reactions.

Our genes contain all the instructions our body needs to function, but their expression must be finely regulated to guarantee that each cell performs its role optimally. This is where DNA and RNA epigenetics come in: a series of mechanisms that act as "markers" on genes,

Our genes contain all the instructions our body needs to function, but their expression must be finely regulated to guarantee that each cell performs

Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy™ cell-free DNA technology. This revolutionary technology represents a significant advancement in synthetic DNA manufacturing,

Researchers engineered a DNA-nanoparticle motor achieving 30 nm/s speed, enhancing performance to rival natural motor proteins for advanced applications.

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer vaccines.